Tedisamil

This publication has 65 references indexed in Scilit:

• Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for “reverse use dependent” block
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1994
• Tedisamil (KC 8857) is a new specific bradycardic drug: Does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease
  American Heart Journal, 1993
• Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs
  Cardiovascular Research, 1992
• Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy
  Cardiovascular Research, 1992
• Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent
  American Heart Journal, 1992
• Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle
  The American Journal of Cardiology, 1991
• Tedisamil blocks single large-conductance Ca2+-activated K+ channels in membrane patches from smooth muscle cells of the guinea-pig portal vein
  Pflügers Archiv - European Journal of Physiology, 1991
• Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: A potential new approach to the management of ischemia-induced malignant ventricular arrhythmias
  American Heart Journal, 1990
• Falipamil (AQ‐A 39) and UL‐FS 49
  Cardiovascular Drug Reviews, 1988
• A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
  The Journal of Clinical Pharmacology, 1984